Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies that bind to human programmed death ligand 1 (PD-L1)

Antibodies that bind to human programmed death ligand 1 (PD-L1)

US Patent 9709568 · Granted Jul 18, 2017

Estimated economic value: $61,300,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MARCO antibodies and uses thereof2025
Anti-TIGIT antibodies2024
Anti-LAG3 antibodies and antigen-binding fragments2024
Anti-TREM1 antibodies and related methods2024
Anti-TIGIT antibodies2024
Plasmid constructs for heterologous protein expression and methods of use2023
Anti-MARCO antibodies and uses thereof2023
Method for the treatment of malignancies2023
Antibody drug conjugate for anti-inflammatory applications2022
Antibodies binding to ILT42022
Systems and methods for improved tissue-sensing based electroporation2022
Anti-LAG3 antibodies and antigen-binding fragments2022